Mahajan, S., Nguyen, L., Weiss, J. A., Kimmick, G. G. (2026). Analysis of eligibility and reporting standards for older patients with hormone receptor–positive, HER2-negative metastatic breast cancer (HR+ MBC) in pivotal phase III clinical trials, 2015-2025.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e13087